VAERS Explorer
Back to explore

Report #2832267

Received Mar 19, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
NM
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
UNKVACCINE NOT SPECIFIED (NO BRAND NAME)UNKNOWN MANUFACTURERUNK——

Symptoms (2)

Pneumococcal infectionVaccination failure

Symptom narrative

the limited protection of PPSV23 against mucosal disease could have made the patient susceptible to the development of IPD; This literature marketed report as received from the authors of a published literature article, and refers to a 66-year-old patient of unknown gender. The patient had a history of tobacco smoking, chronic obstructive pulmonary disease, and poorly controlled diabetes. On an unknown date in 2019 (reported as 3 years prior), the patient was vaccinated with pneumococcal Vaccine, Polyvalent (23-valent) for prophylaxis (strength, dose, route of administration, anatomical location, lot number, and expiration date were not reported). It was reported, the patient had presence of multiple comorbidities and the limited protection of PPSV23 against mucosal disease could have made the patient development of invasive pneumococcal disease (IPD) (Vaccination failure). The event vaccination failure was considered to be related to pneumococcal Vaccine, Polyvalent (23-valent).

Current illness

Chronic obstructive pulmonary disease; Diabetes mellitus poor control; Tobacco user